We use necessary cookies to make our website work. We also use optional statistical, functional and marketing cookies that you can choose to decline in your preference setting. For more information about the use of cookies or our use of data, see our Cookies notice or Privacy notice

Cookies settings I agree I refuse

Cookies information

Our site uses tools, such as cookies, to analyze and improve your experience. You can unsubscribe below:

Statistics

We use tools, such as Google Analytics, to track web traffic and verify the effectiveness of our site.

Necessary

Cookies required for essential services and features such as login forms, shopping cart integration and access control. Without them, our website cannot function properly and we cannot provide any services. Deactivation is not available.

These settings will be kept for 24h

Events

Bio€quity Europe 2023

Bio€quity Europe 2023
Check the link
Events
Bio€quity Europe 2023

Marc Dechamps, CEO of Bioxodes, will give a presentation as part of the ‘Autoimmune, Inflammation and Thrombosis’ track.

The presentation, titled: ‘Bioxodes, a clinical stage company developing a first-in-class drug candidate against thrombosis and neuroinflammation starting with Hemorrhagic Stroke’, will be held in the Liffey meeting room on May 15, at 11:18am IST. The presentation will also be available on BioCentury’s partneringONE® platform.